Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. (2022)

First Author: RECOVERY Collaborative Group
Attributed to:  Randomised trials in cardiovascular and metabolic disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(22)01109-6

PubMed Identifier: 35908569

Publication URI: http://europepmc.org/abstract/MED/35908569

Type: Journal Article/Review

Volume: 400

Parent Publication: Lancet (London, England)

Issue: 10349

ISSN: 0140-6736